M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.

Backed by more than three decades of clinical evidence and innovation, the prodisc platform continues to advance total disc ...

Results showed anterior lumbar interbody fusion with posterior pedicle screw fixation may be effective and cost efficient and pose minimal complications within the immediate postoperative period when ...

The spine field has seen important advances in treatments but there are some areas that have yet to be solved, Roger Härtl, MD, said. Dr. Härtl, of Och Spine at NewYork-Presbyterian/Weill Cornell ...

As spine leaders look ahead to 2026, enthusiasm around regenerative medicine and neuromodulation continues to build. But much of the conversation still flattens a field that is far more complex than ...